ASX - Delayed Quote AUD

CD Private Equity Fund II (CD2.AX)

Compare
0.8300
0.0000
(0.00%)
At close: April 2 at 3:33:05 PM GMT+11
Loading Chart for CD2.AX
  • Previous Close 0.8300
  • Open 0.8300
  • Bid 0.8100 x --
  • Ask 0.8450 x --
  • Day's Range 0.8300 - 0.8300
  • 52 Week Range 0.7900 - 1.1200
  • Volume 5,250
  • Avg. Volume 19,732
  • Market Cap (intraday) 43.558M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 4.15
  • EPS (TTM) 0.2000
  • Earnings Date May 28, 2025 - Jun 2, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Aug 17, 2023
  • 1y Target Est --

CD Private Equity Fund II is a co-sponsored fund of Cordish Private Ventures LLC and Dixon Advisory and Superannuation Services Pty Ltd., Investment Arm. It specializes in fund of fund investments. It targets investing in small-to-mid-market private investment funds and unlisted opportunities in United States.

www.cdfunds.com.au/fund2/

--

Full Time Employees

--

Fiscal Year Ends

Recent News: CD2.AX

View More

Performance Overview: CD2.AX

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

CD2.AX
6.73%
S&P/ASX 200 [XJO] (^AXJO)
6.02%

1-Year Return

CD2.AX
10.53%
S&P/ASX 200 [XJO] (^AXJO)
1.36%

3-Year Return

CD2.AX
5.55%
S&P/ASX 200 [XJO] (^AXJO)
2.05%

5-Year Return

CD2.AX
165.31%
S&P/ASX 200 [XJO] (^AXJO)
51.31%

Compare To: CD2.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CD2.AX

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    43.56M

  • Enterprise Value

    --

  • Trailing P/E

    4.16

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    298.87

  • Price/Book (mrq)

    0.63

  • Enterprise Value/Revenue

    298.87

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    0.2000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: CD2.AX

View More

Company Insights: CD2.AX

Research Reports: CD2.AX

View More

People Also Watch